(Q33607793)

English

Modification of a simple clinical scoring system as a diagnostic screening tool for non-alcoholic steatohepatitis in Japanese patients with non-alcoholic fatty liver disease

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Modification of a simple clinical scoring system as a diagnostic screening tool for non-alcoholic steatohepatitis in Japanese patients with non-alcoholic fatty liver disease (English)

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

steatohepatitis

0 references

non-alcoholic fatty liver

1 reference

based on heuristic

inferred from title

non-alcoholic steatohepatitis

1 reference

based on heuristic

inferred from title

metabolic dysfunction–associated steatotic liver disease

1 reference

based on heuristic

inferred from title

Atsushi Nakajima

12

object named as

Atsushi Nakajima

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

2

object named as

Masato Yoneda

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

6

object named as

Hideyuki Hyogo

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

author name string

Akinobu Nakamura

1

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Yoshio Sumida

3

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Yuichiro Eguchi

4

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Hideki Fujii

5

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Masafumi Ono

7

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Yasuaki Suzuki

8

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Takumi Kawaguchi

9

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Noriaki Aoki

10

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Takeshi Okanoue

11

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Shin Maeda

13

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Yasuo Terauchi

14

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

publication date

19 May 2013

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Journal of Diabetes Investigation

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

6

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

651-658

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Impact of glucose tolerance on the severity of non-alcoholic steatohepatitis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4020262

21 June 2018

Report of the committee on the classification and diagnostic criteria of diabetes mellitus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4020262

21 June 2018

Impact of current treatments on liver disease, glucose metabolism and cardiovascular risk in non-alcoholic fatty liver disease (NAFLD): a systematic review and meta-analysis of randomised trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4020262

21 June 2018

Meta-analysis: natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4020262

21 June 2018

Nonalcoholic fatty liver disease and hepatocellular carcinoma: a weighty connection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4020262

21 June 2018

Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: Selected practical issues in their evaluation and management

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4020262

21 June 2018

Noninvasive diagnosis and monitoring of nonalcoholic steatohepatitis: present and future

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4020262

21 June 2018

Long-term follow-up of patients with NAFLD and elevated liver enzymes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4020262

21 June 2018

Clinical features of nonalcoholic steatohepatitis in Japan: Evidence from the literature

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4020262

21 June 2018

Nonalcoholic steatohepatitis: Summary of an AASLD Single Topic Conference

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4020262

21 June 2018

Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4020262

21 June 2018

AGA technical review on nonalcoholic fatty liver disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4020262

21 June 2018

Nonalcoholic steatohepatitis, insulin resistance, and metabolic syndrome: further evidence for an etiologic association

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4020262

21 June 2018

Nonalcoholic fatty liver disease: predictors of nonalcoholic steatohepatitis and liver fibrosis in the severely obese

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4020262

21 June 2018

Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4020262

21 June 2018

Epidemiology of non-alcoholic fatty liver disease.

1 reference

https://api.crossref.org/works/10.1111%2FJDI.12101

21 January 2018

Prevalence and associated metabolic factors of nonalcoholic fatty liver disease in the general population from 2009 to 2010 in Japan: a multicenter large retrospective study

1 reference

https://api.crossref.org/works/10.1111%2FJDI.12101

21 January 2018

A simple clinical scoring system using ferritin, fasting insulin, and type IV collagen 7S for predicting steatohepatitis in nonalcoholic fatty liver disease.

1 reference

https://api.crossref.org/works/10.1111%2FJDI.12101

21 January 2018

Development and validation of a simple NAFLD clinical scoring system for identifying patients without advanced disease.

1 reference

https://api.crossref.org/works/10.1111%2FJDI.12101

21 January 2018

NASH and insulin resistance: Insulin hypersecretion and specific association with the insulin resistance syndrome

1 reference

https://api.crossref.org/works/10.1111%2FJDI.12101

21 January 2018

Prospective study of the long-term effects of bariatric surgery on liver injury in patients without advanced disease

1 reference

https://api.crossref.org/works/10.1111%2FJDI.12101

21 January 2018

Applicability of BARD score to Japanese patients with NAFLD

1 reference

https://pubmed.ncbi.nlm.nih.gov/24843721

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Protection from non-alcoholic steatohepatitis and liver tumourigenesis in high fat-fed insulin receptor substrate-1-knockout mice despite insulin resistance

1 reference

https://pubmed.ncbi.nlm.nih.gov/24843721

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Usefulness of a combined evaluation of the serum adiponectin level, HOMA-IR, and serum type IV collagen 7S level to predict the early stage of nonalcoholic steatohepatitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/24843721

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Type IV collagen 7s domain is an independent clinical marker of the severity of fibrosis in patients with nonalcoholic steatohepatitis before the cirrhotic stage

1 reference

https://pubmed.ncbi.nlm.nih.gov/24843721

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1111/JDI.12101

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33607793&oldid=1988615469"